BioLine Rx Ltd (BLRX)
0.2664
-0.06
(-17.59%)
USD |
NASDAQ |
Nov 22, 14:29
BioLine Rx Total Assets (Quarterly): 64.60M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 64.60M |
| March 31, 2024 | 51.60M |
| December 31, 2023 | 63.92M |
| September 30, 2023 | 52.86M |
| June 30, 2023 | 58.94M |
| March 31, 2023 | 68.65M |
| December 31, 2022 | 76.38M |
| September 30, 2022 | 81.67M |
| June 30, 2022 | 67.84M |
| March 31, 2022 | 74.77M |
| December 31, 2021 | 81.39M |
| September 30, 2021 | 86.90M |
| June 30, 2021 | 91.33M |
| March 31, 2021 | 83.60M |
| December 31, 2020 | 47.29M |
| September 30, 2020 | 46.04M |
| June 30, 2020 | 52.99M |
| March 31, 2020 | 47.17M |
| December 31, 2019 | 53.57M |
| September 30, 2019 | 57.22M |
| June 30, 2019 | 61.96M |
| March 31, 2019 | 67.59M |
| December 31, 2018 | 56.23M |
| September 30, 2018 | 46.40M |
| June 30, 2018 | 52.21M |
| Date | Value |
|---|---|
| March 31, 2018 | 56.08M |
| December 31, 2017 | 60.96M |
| September 30, 2017 | 66.13M |
| June 30, 2017 | 63.05M |
| March 31, 2017 | 41.12M |
| December 31, 2016 | 38.94M |
| September 30, 2016 | 42.28M |
| June 30, 2016 | 45.68M |
| March 31, 2016 | 48.94M |
| December 31, 2015 | 51.30M |
| September 30, 2015 | 55.03M |
| June 30, 2015 | 58.36M |
| March 31, 2015 | 59.87M |
| December 31, 2014 | 36.21M |
| September 30, 2014 | 30.96M |
| June 30, 2014 | 35.03M |
| March 31, 2014 | 38.98M |
| December 31, 2013 | 20.02M |
| September 30, 2013 | 22.14M |
| June 30, 2013 | 24.96M |
| March 31, 2013 | 30.66M |
| December 31, 2012 | 24.31M |
| September 30, 2012 | 28.16M |
| June 30, 2012 | 33.34M |
| March 31, 2012 | 39.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
46.04M
Minimum
Sep 2020
91.33M
Maximum
Jun 2021
65.87M
Average
64.60M
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| Compugen Ltd | 123.52M |
| Pluri Inc | 35.44M |
| XTL Biopharmaceuticals Ltd | 2.928M |
| Can Fite Biofarma Ltd | 9.989M |
| BiomX Inc | 59.98M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.62M |
| Shareholders Equity (Quarterly) | 13.98M |
| Debt to Equity Ratio | 2.106 |
| Current Ratio | 1.609 |
| Net Debt Paydown Yield | -8.19% |